Please use this identifier to cite or link to this item: http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/12709
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMikulets, L.V.-
dc.contributor.authorIlashchuk, T.O.-
dc.date.accessioned2017-09-05T07:34:22Z-
dc.date.available2017-09-05T07:34:22Z-
dc.date.issued2017-05-14-
dc.identifier.issn1468-2060-
dc.identifier.issn0003-4967-
dc.identifier.otherDOI: 10.1136/annrheumdis-2017-eular.-
dc.identifier.urihttp://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/12709-
dc.description.abstractInclusion in the complex therapy of patients with RA statins contributes to a significant reduction in total cholesterol, LDL cholesterol, and positively affects the activity of the process, reducing the levels of acute phase proteins. Additional indications for the purpose of statins have high activity process and late onset. The use of statins in RA, given their lipid-lowering and anti-inflammatory effects, may be an effective means for the successful prevention of cardiovascular complications.ru_RU
dc.description.sponsorshipКафедра пропедевтики внутрішніх хворобru_RU
dc.language.isoenru_RU
dc.publisherAnnals of the Rheumatic Diseases. The EULAR journal. - Annual European Congress of Rheumatology. - 2017. - Vol. 76. - Suppl. 2. - P. 1167.ru_RU
dc.relation.ispartofseriesAnnals of the Rheumatic Diseases. The EULAR journal. - Annual European Congress of Rheumatology;AB0340-
dc.subjectstatinsru_RU
dc.subjectстатиниru_RU
dc.subjectrheumatoid arthritisru_RU
dc.subjectревматоїдний артритru_RU
dc.titleCLINICAL EFFICACY OF STATINS IN PATIENTS WITH RHEUMATOID ARTHRITISru_RU
dc.typeOtherru_RU
Appears in Collections:Тези. Кафедра пропедевтики внутрішніх хвороб

Files in This Item:
File SizeFormat 
72721549078213197022748317331716938310.pdf208.04 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.